国家疾控局：我国尚未发现尼帕病毒病病例，请不必过度恐慌

Core Viewpoint - The outbreak of Nipah virus in India has raised global concerns, but China has not reported any cases and urges the public not to panic [1][4]. Group 1: Nipah Virus Overview - Nipah virus is a zoonotic RNA virus primarily carried by fruit bats and pigs, with a mortality rate ranging from 40% to 75% and an incubation period of 4 to 14 days [1]. - There is currently no specific vaccine or effective treatment for Nipah virus, and management focuses on symptom control and supportive care [1][4]. Group 2: Current Situation in India - As of January 24, five cases of Nipah virus infection have been reported in West Bengal, India, including two nurses who treated a deceased woman showing symptoms consistent with Nipah virus infection [1]. - Investigations revealed that while no Nipah virus was found in bats in the area, antibodies indicating past exposure to the virus were detected in one bat [1]. Group 3: China's Response - The National Health Commission of China has stated that the Nipah virus outbreak in India poses a relatively low risk to China, as there is no land border with the affected area [2]. - China has enhanced monitoring and prevention measures, including training healthcare professionals and strengthening response capabilities at border areas [4]. Group 4: Research Developments - Recent research from the Wuhan Institute of Virology has confirmed that the oral nucleoside drug VV116 shows significant antiviral activity against Nipah virus, providing new hope for treatment [5]. - VV116 could serve as a preventive medication for high-risk groups such as healthcare workers and laboratory personnel, offering a potential option for current and future Nipah virus outbreaks [6].